The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months
Annals of Internal Medicine · 2025-05 · 178 (5) · 634-644
DOI: 10.7326/annals-24-01631 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Internal Medicine, 2025-05. Verfasst von Victoria A Catenacci und 16 weiteren Autor:innen. Beteiligte Einrichtung: Anschutz Health and Wellness Center, University of Colorado, School of Medicine, Anschutz Medical Campus, and Division of Endocrinology, Metabolism, …. Hauptthemen laut MEDLINE: Weight Loss, Fasting, Caloric Restriction, Obesity. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Long-term (≥12 months) randomized trials evaluating the efficacy of intermittent fasting (IMF) as a dietary weight loss strategy are limited. Furthermore, no studies have compared IMF versus daily caloric restriction (DCR) when both interventions are provided in the context of a guidelines-based behavioral weight loss program. OBJECTIVE: To compare the effects of 4:3 IMF versus DCR on changes in weight at 12 months, with comprehensive behavioral support provided to both groups. DESIGN: Randomized clinical trial. (ClinicalTrials.gov: NCT03411356). SETTING: Denver, Colorado, and surrounding metropolitan area. PARTICIPANTS: Adults aged 18 to 60 years with body mass index (BMI) of 27 to 46 kg/m2. INTERVENTION: The IMF group was instructed to restrict energy intake by 80% on 3 nonconsecutive days per week, with ad libitum intake (no restriction) the other 4 days (4:3 IMF). The DCR group was instructed to reduce daily energy intake by 34% to match the weekly energy deficit of 4:3 IMF. Both groups received a high-intensity comprehensive behavioral weight loss program that included group-based behavioral support and a recommendation to increase moderate-intensity physical activity to 300 minutes per week. MEASUREMENTS: The primary outcome was change in body weight (in kilograms) at 12 months. RESULTS: Of the 165 (4:3 IMF, n = 84; DCR, n = 81) randomly assigned participants (mean age, 42 years [SD, 9]; mean BMI, 34.1 kg/m2 [SD, 4.4]; 73.9% female), 125 completed the trial. In an intention-to-treat analysis, 4:3 IMF showed greater reductions in weight than DCR at 12 months (mean difference, 2.89 kg [95% CI, 5.65 to 0.14 kg]; P = 0.040). LIMITATION: Limited generalizability. CONCLUSION: Compared with DCR, 4:3 IMF resulted in modestly greater weight loss among adults with overweight or obesity enrolled in a 12-month, high-intensity, comprehensive behavioral weight loss program. PRIMARY FUNDING SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Anschutz Health and Wellness Center, University of Colorado, School of Medicine, Anschutz Medical Campus, and Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz…
- Anschutz Health and Wellness Center, University of Colorado, School of Medicine, Anschutz Medical Campus, Aurora, Colorado; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colo…
- Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado (Z.P., L.K.K.).
- Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, and Division of Endocrinology, Metabolism, and Diabetes, Department of Medic…
- Department of Biology, United States Air Force Academy, Colorado Springs, Colorado (J.D.).
- School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado (B.S.).
ORCID-Profile: Danielle M Ostendorf, Laura K Kaizer, Seth A Creasy, Adnin Zaman, Ann E Caldwell, Matthew J Breit, Jared J Scorsone, Edward L Melanson
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Catenacci, V. A., Ostendorf, D. M., Pan, Z., Kaizer, L. K., Creasy, S. A., Zaman, A., Caldwell, A. E., Dahle, J., Swanson, B., Breit, M. J., Bing, K., Wayland, L. T., Panter, S. L., Scorsone, J. J., Bessesen, D. H., MacLean, P., & Melanson, E. L. (2025). The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months. Annals of Internal Medicine, 178(5), 634-644. https://doi.org/10.7326/annals-24-01631
Vancouver
Catenacci VA, Ostendorf DM, Pan Z, Kaizer LK, Creasy SA, Zaman A, et al. The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months. Annals of Internal Medicine. 2025;178(5):634-644. doi:10.7326/annals-24-01631
BibTeX
@article{Catenacci2025,
author = {Catenacci, Victoria A and Ostendorf, Danielle M and Pan, Zhaoxing and Kaizer, Laura K and Creasy, Seth A and Zaman, Adnin and Caldwell, Ann E and Dahle, Jared and Swanson, Bryan and Breit, Matthew J and Bing, Kristen and Wayland, Liza T and Panter, Shelby L and Scorsone, Jared J and Bessesen, Daniel H and MacLean, Paul and Melanson, Edward L},
title = {The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months},
journal = {Annals of Internal Medicine},
year = {2025},
volume = {178},
number = {5},
pages = {634--644},
doi = {10.7326/annals-24-01631}
}
EUVIMED